![]() |
市場調査レポート
商品コード
1706733
塞栓用粒子の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、介入、予測(~2036年)Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
カスタマイズ可能
適宜更新あり
|
塞栓用粒子の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、介入、予測(~2036年) |
出版日: 2025年02月19日
発行: GlobalData
ページ情報: 英文 53 Pages
納期: 即納可能
![]() |
当レポートでは、世界の塞栓用粒子市場について調査分析し、各地域の市場規模、主要動向、革新的な製品と技術、競合情勢などの情報を提供しています。
市場モデルの主な内容は以下の通りです。
上市済みの塞栓用粒子と進化する競合情勢
世界、地域、国レベルの各市場の考察
医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。
対象企業
Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.
Embolization is a procedure that uses particles such as tiny gelatin sponges or beads to block a blood vessel. Embolization Particles are used to stop bleeding or are used to block the flow of blood to a tumor. Embolization Particles are generally used to treat liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and benign prostatic hyperplasia. Embolization particles can be categorized into four segments based on composition and mechanism of action: Polyvinyl Alcohol (PVA) Particles, Microspheres, Drug-Eluting Beads, Radioembolization Particles.
The embolization particles market is driven by a wide variety of factors including aging population, growing number of patients with liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids and benign prostatic hyperplasia.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Embolization Particles and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Merit Medical Systems Inc, Sirtex Medical Ltd, Terumo Corp, Wilson-Cook Medical Inc, Varian Medical Systems Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable